• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沸石中用于治疗骨质疏松症的药物释放-离子类型和药物对释放特性的影响。

Release of drugs used in the treatment of osteoporosis from zeolites with divalent ions-Influence of the type of ion and drug on the release profile.

机构信息

Institute of Chemical Technology and Engineering, Poznan University of Technology, Poznań, Poland.

Institute of Building Engineering, Poznan University of Technology, Poznań, Poland.

出版信息

J Biomed Mater Res B Appl Biomater. 2023 May;111(5):1005-1014. doi: 10.1002/jbm.b.35209. Epub 2022 Nov 30.

DOI:10.1002/jbm.b.35209
PMID:36451589
Abstract

Bisphosphonates are drugs that are used to treat osteoporosis that causes the low mineral density of the bones. These drugs can be delivered in several ways, but each method has disadvantages. Materials with high potential as carriers of these drugs are zeolites with divalent ions. The aim of this study was to investigate the effect of divalent cations (calcium, magnesium, zinc) and drug type (risedronate, zoledronate) on sorption and release of the drug for osteoporosis. It was proved that drug sorption occurs on all zeolites presented in this work. Risedronate sorption was highest in zinc zeolite and lowest in calcium zeolite. In the case of zoledronate, sorption was most effective in magnesium zeolite and the least effective in zinc zeolite. Very large differences in drug release profiles were also observed. Risedronate was released several times longer than zoledronate. The diversity of the results indicates that the examined materials can be used in different types of drug delivery systems. They can be used, for example, intravenously or in the form of implants due to the different release profiles. Furthermore, the proposed carriers also release magnesium and calcium ions which are used in the prevention of osteoporosis, and zinc ions which have antibacterial properties.

摘要

双膦酸盐是用于治疗骨质疏松症的药物,骨质疏松症会导致骨骼矿物质密度降低。这些药物可以通过几种方式给药,但每种方法都有缺点。具有高潜力作为这些药物载体的材料是具有二价离子的沸石。本研究的目的是研究二价阳离子(钙、镁、锌)和药物类型(利塞膦酸盐、唑来膦酸盐)对骨质疏松症药物的吸附和释放的影响。事实证明,所有在这项工作中呈现的沸石都能吸附药物。在锌沸石中,利塞膦酸盐的吸附率最高,在钙沸石中最低。对于唑来膦酸盐,在镁沸石中的吸附效果最佳,在锌沸石中效果最差。药物释放曲线也存在非常大的差异。利塞膦酸盐的释放时间比唑来膦酸盐长几倍。结果的多样性表明,所研究的材料可用于不同类型的药物输送系统。由于释放曲线不同,它们可以用于静脉内或植入物的形式。此外,所提出的载体还释放用于预防骨质疏松症的镁和钙离子以及具有抗菌性能的锌离子。

相似文献

1
Release of drugs used in the treatment of osteoporosis from zeolites with divalent ions-Influence of the type of ion and drug on the release profile.沸石中用于治疗骨质疏松症的药物释放-离子类型和药物对释放特性的影响。
J Biomed Mater Res B Appl Biomater. 2023 May;111(5):1005-1014. doi: 10.1002/jbm.b.35209. Epub 2022 Nov 30.
2
Zeolites with Divalent Ions as Carriers in the Delivery of Epigallocatechin Gallate.载二价离子沸石在表没食子儿茶素没食子酸酯传递中的应用。
ACS Biomater Sci Eng. 2023 Sep 11;9(9):5322-5331. doi: 10.1021/acsbiomaterials.3c00599. Epub 2023 Aug 4.
3
Calcium zeolites as intelligent carriers in controlled release of bisphosphonates.钙沸石作为控制释放双膦酸盐的智能载体。
Int J Pharm. 2020 Mar 30;578:119117. doi: 10.1016/j.ijpharm.2020.119117. Epub 2020 Feb 5.
4
Zeolitic Imidazolate Framework‑8 (ZIF-8) modified titanium alloy for controlled release of drugs for osteoporosis.用于骨质疏松症药物控释的沸石咪唑酯骨架-8(ZIF-8)修饰钛合金
Sci Rep. 2022 Jun 1;12(1):9103. doi: 10.1038/s41598-022-13187-0.
5
Drug distribution evaluation using FT-IR imaging on the surface of a titanium alloy coated with zinc titanate with potential application in the release of drugs for osteoporosis.采用 FT-IR 成像技术对涂有钛酸锌的钛合金表面进行药物分布评估,该技术具有在骨质疏松症药物释放方面的潜在应用。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Nov 15;281:121575. doi: 10.1016/j.saa.2022.121575. Epub 2022 Jul 2.
6
Controlled release of the drug for osteoporosis from the surface of titanium implants coated with calcium titanate.药物从涂有钛酸钙的钛植入物表面实现骨质疏松症药物的控释。
J Biomed Mater Res B Appl Biomater. 2022 Feb;110(2):431-437. doi: 10.1002/jbm.b.34919. Epub 2021 Jul 21.
7
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.唑来膦酸和利塞膦酸预防和治疗糖皮质激素性骨质疏松症(HORIZON):一项多中心、双盲、双模拟、随机对照试验。
Lancet. 2009 Apr 11;373(9671):1253-63. doi: 10.1016/S0140-6736(09)60250-6.
8
Removal of calcium and magnesium ions from shale gas flowback water by chemically activated zeolite.化学活化沸石去除页岩气返排水中的钙镁离子
Water Sci Technol. 2017 Jul;76(3-4):575-583. doi: 10.2166/wst.2017.237.
9
Characterization of Magnesium and Zinc Forms of Sodalite Coatings on Ti6Al4V ELI for Potential Application in the Release of Drugs for Osteoporosis.用于骨质疏松症药物释放潜在应用的Ti6Al4V ELI上钠沸石涂层的镁和锌形态表征。
Materials (Basel). 2023 Feb 17;16(4):1710. doi: 10.3390/ma16041710.
10
Antimicrobial properties of zeolite-X and zeolite-A ion-exchanged with silver, copper, and zinc against a broad range of microorganisms.用银、铜和锌进行离子交换的X型沸石和A型沸石对多种微生物的抗菌特性。
Appl Biochem Biotechnol. 2014 Feb;172(3):1652-62. doi: 10.1007/s12010-013-0647-7. Epub 2013 Nov 17.

引用本文的文献

1
Impact of Octahedral Aluminum Sites on Guest Molecule Adsorption in Zeolites: A Computational Study of 5-Fluorouracil in Zeolite FAU.八面体铝位点对沸石中客体分子吸附的影响:沸石FAU中5-氟尿嘧啶的计算研究
Chemistry. 2025 Jun 6;31(32):e202500833. doi: 10.1002/chem.202500833. Epub 2025 May 2.
2
Zeolites with Divalent Ions as Carriers in the Delivery of Epigallocatechin Gallate.载二价离子沸石在表没食子儿茶素没食子酸酯传递中的应用。
ACS Biomater Sci Eng. 2023 Sep 11;9(9):5322-5331. doi: 10.1021/acsbiomaterials.3c00599. Epub 2023 Aug 4.
3
Characterization of Magnesium and Zinc Forms of Sodalite Coatings on Ti6Al4V ELI for Potential Application in the Release of Drugs for Osteoporosis.
用于骨质疏松症药物释放潜在应用的Ti6Al4V ELI上钠沸石涂层的镁和锌形态表征。
Materials (Basel). 2023 Feb 17;16(4):1710. doi: 10.3390/ma16041710.